Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
|Videos|October 1, 2020
COVID-19 and its Effect on Patients with Addiction
Author(s)Cornel N. Stanciu, MD, MRO
Addiction is a disease of social nature. The interruption of normalcy, even for those in a period of sobriety, can be especially hard on patients with addiction.
Advertisement
Dr Stanciu is Addiction Section Editor for Psychiatric Times. He is Assistant Professor of Psychiatry at Dartmouth’s Geisel School of Medicine and Director of Addiction Services at New Hampshire Hospital, Concord, NH.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
2
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
3
Adjustment Disorder Is Hiding in Plain Sight
4
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
5